ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY – Trademark Portfolio
Entity Type: 16
ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ANAHEIM GARDENWALK. The owner is based in NEW YORK, NY.
399 PARK AVENUE 6TH FLOOR
NEW YORK, NY 10022
Showing of trademarks Trademarks
Trademark Classifications
ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY have?
ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY file in?
ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY files trademarks across 1 Nice Classification class. The most active classes are Class 37 (Building & Construction). Class 37 covers building construction; repair; installation services.
What are ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY's most well-known trademarks?
ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY's registered trademark portfolio includes well-known marks such as ANAHEIM GARDENWALK. These are among 1 currently registered trademark in the portfolio.
What is ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY's trademark registration success rate?
ANAHEIM CAPITAL PARTNERS LLC, A DELAWARE LIMITED LIABILITY COMPANY has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.